Verax Biomedical™ Platelet PGD™ Test System

Rapid test for the detection of Gram-positive and Gram-negative bacterial contamination in platelets. FDA cleared as a Safety Measure allowing the extension of platelet dating from 5 to 7 days when testing leukocyte reduced apheresis platelets suspended in plasma.

Catalog Number	Mfr. No.	Quantity
23-051-000	Verax Biomedical™ P100	100 Tests
23-051-001	Verax Biomedical™ P20	20 Tests

Description

• Visual, three-step test for the qualitative detection of bacterial contamination
• Detects aerobes and anaerobes
• Detection rate: 1:3069 in early culture screened leukoreduced apheresis platelets
• Specificity: 99.9% in leukoreduced apheresis platelets
• 500uL sample size
• Includes disposables required to perform the test
• Ready to use liquid reagents in dropper bottles
• Gram-positive and Gram-negative read windows
• Colored line in read window indicates a reactive result
• Built in procedural controls verify assay validity
• FDA cleared for use with: leukoreduced apheresis platelets in plasma or PAS-C, pools of up to 6 pre-storage or post storage pooled platelets and individual WBD platelets
• CLIA Complexity: Moderate

Specifications

• CE Marker: No
• Format: Lateral Flow
• Reagents Included: Yes
• Sample Type: Platelet
• Storage Requirements: 15°C to 30°C and 2°C to 8°C

• Clia Complexity: Moderate
• Packaging: Cartons
• Sample Size: 500 µL
• Shelf Life: >3 Months